Clinical Trial Update: A Clinical Study to Evaluate the Sensitizing Potential of LEO 43204 Gel [Phase 1]

View source ↗

Summary

Phase 1 study evaluating the sensitizing potential of LEO 43204 Gel in actinic keratosis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Actinic Keratosis

Drugs mentioned

• LEO 43204 Gel

Snippet

Sponsor: LEO Pharma | Conditions: Actinic Keratosis | Phase 1 | Status: COMPLETED